Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-25-027404
Filing Date
2025-07-25
Accepted
2025-07-25 18:12:54
Documents
1
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3824
  Complete submission text file 0001140361-25-027404.txt   5301
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Issuer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address
Shepard Kirk V. (Reporting) CIK: 0002009007 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37568 | Film No.: 251152659